Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Asparaginase Enzyme Activity Levels and Toxicity in Childhood Acute Lymphoblastic Leukemia: a NOPHO ALL2008 study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evans syndrome in adults: an observational multicenter study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

Acute graft-versus-host disease (aGVHD) is a leading cause of transplantation-related mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). 16S ribosomal RNA (16S rRNA) gene-based studies have reported that lower gut bacterial diversity and the relative abundance of certain bacteria after aHSCT are associated with aGVHD. Using shotgun metagenomic sequencing and a large cohort, we aimed to confirm and extend these observations. Adult aHSCT recipients with stool samples collected from day -30 to day 100 relative to aHSCT were included. One sample was selected per patient per period (pre-aHSCT (day -30 to day 0), early post-aHSCT (day 1 to day 28), and late post-aHSCT (day 29 to day 100)), resulting in 150 aHSCT recipients and 259 samples. Microbial and clinical factors were tested for differences between time periods and an association with subsequent aGVHD. Patients showed a decline in gut bacterial diversity posttransplant, with several patients developing a dominance of Enterococcus. A total of 36 recipients developed aGVHD at a median of 34 days (interquartile range, 26-50 days) post-aHSCT. Lower microbial gene richness (P = .02), a lower abundance of the genus Blautia (P = .05), and a lower abundance of Akkermansia muciniphila (P = .01) early post-aHSCT was observed in those who developed aGVHD. Myeloablative conditioning was associated with aGVHD along with a reduction in gene richness and abundance of Blautia and A muciniphila. These results confirm low diversity and Blautia being associated with aGVHD. Crucially, we add that pretransplant conditioning is associated with changes in gut microbiota. Investigations are warranted to determine the interplay of gut microbiota and conditioning in the development of aGVHD.

Original languageEnglish
JournalBlood advances
Volume4
Issue number22
Pages (from-to)5797-5809
Number of pages13
ISSN2473-9529
DOIs
Publication statusPublished - 24 Nov 2020

ID: 61324109